Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment
0107020J0AAAGAG
|
Hydrocortisone compound preparations | Hydrocortisone | Gastro-Intestinal System | 3,918 |
|
Anusol Plus HC ointment
0107020J0BCACAC
|
Anusol HC | Hydrocortisone | Gastro-Intestinal System | 3,642 |
|
Hydrocortisone 0.1% cream
1304000V0AAAWAW
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 2,898 |
|
Otosporin ear drops
1201010Q0BCAAAC
|
Otosporin | Hydrocortisone | Ear, Nose and Oropharynx | 2,654 |
|
Hydrocortisone 2.5% cream
1304000V0AAAFAF
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 2,624 |
|
Hydrocortisone 2.5mg tablets
0603020J0AADCDC
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 2,426 |
|
Hydventia 10mg tablets
0603020J0BGAAAD
|
Hydventia | Hydrocortisone | Endocrine System | 2,338 |
|
Anusol Plus HC suppositories
0107020J0BCADAB
|
Anusol HC | Hydrocortisone | Gastro-Intestinal System | 2,335 |
|
Eurax Hc cream
1304000V0BTABAJ
|
Eurax-Hydrocortisone | Hydrocortisone | Skin | 1,766 |
|
Nystatin 100,000units/g/Chlorhex Hcl 1% / Hydrocort 0.5% crm
1304000V0AACFCF
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 1,651 |
|
Terra-Cortril ointment (Intrapharm)
1304000V0CCAFCM
|
Terra-Cortril (Topical) | Hydrocortisone | Skin | 1,514 |
|
Hydrocortisone 2.5% ointment
1304000V0AABDBD
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 1,197 |
|
Hydrocortisone 5mg/5ml oral suspension
0603020J0AAAXAX
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 1,077 |
|
Hydrocortisone 0.25% / Crotamiton 10% cream
1304000V0AAAJAJ
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 1,012 |
|
Nystaform HC ointment
1304000V0CFACCN
|
Nystaform-HC | Hydrocortisone | Skin | 931 |
|
Nystatin 100,000u/g / Chlorhex acetate 1%/ Hydrocort 1% oint
1304000V0AACNCN
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 885 |
|
Hydrocortisone 5mg modified-release tablets
0603020J0AACVCV
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 721 |
|
Hydrocortisone 5mg/5ml oral solution sugar free
0603020J0AADKDK
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 692 |
|
Oxytetracycline 3% / Hydrocortisone 1% ointment
1304000V0AACMCM
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 553 |
|
Alkindi 2mg granules in capsules for opening
0603020J0BFACCZ
|
Alkindi | Hydrocortisone | Endocrine System | 478 |
|
Alkindi 1mg granules in capsules for opening
0603020J0BFABCY
|
Alkindi | Hydrocortisone | Endocrine System | 441 |
|
Hydrocortisone 10mg soluble tablets sugar free
0603020J0AADBDB
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 415 |
|
Canesten Hydrocortisone cream
1304000V0CHACCI
|
Canesten (hydrocortisone) | Hydrocortisone | Skin | 394 |
|
Hydrocortisone 15mg tablets
0603020J0AADEDE
|
Hydrocortisone (Systemic) | Hydrocortisone | Endocrine System | 312 |
|
Mildison Lipocream 1% cream
1304000V0BQAAAD
|
Mildison Lipocream | Hydrocortisone | Skin | 294 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.